The U.S. Securities and Alternate Fee has paused Nasdaq’s approval of cash-settled bitcoin index choices and can rethink the choice following a authorized problem from CME Group.
The company laid this out in an order launched for public inspection on July 31.
How the approval unfolded
Again in Might, the SEC granted Nasdaq PHLX conditional approval to checklist cash-settled bitcoin index choices below the ticker QBTC.
The product nonetheless required exemptions from the Commodity Futures Buying and selling Fee (CFTC) earlier than it might launch.
CME Group challenged the approval in June, arguing that bitcoin is a commodity and, as such, choices tied on to its worth fall below the CFTC’s unique jurisdiction reasonably than the SEC’s.
What CME’s argument means
If the CME is true, the SEC would don’t have any authority to approve QBTC.
Nasdaq would then must register as a CFTC-regulated futures or swaps venue, or redesign the contracts to trace a safety resembling a spot bitcoin exchange-traded fund.
The CME already operates regulated bitcoin futures and choices markets, whereas Nasdaq’s QBTC would compete for a similar buying and selling exercise with out registering below the CFTC framework that governs the CME.
The petition additionally warned the approval might set a precedent permitting securities exchanges to checklist derivatives on different commodities.
Nasdaq’s proposed contracts would use CME CF benchmarks for each their underlying index and remaining settlement value.
Evaluation timeline
The order retains the approval frozen and provides events till Aug. 24 to submit statements supporting or opposing it.
The keep has been in place since CME filed discover of its problem on June 11.
The CME argued the companies can not use exemptions to switch a product from one regulator to a different. QBTC will stay suspended whereas the total fee critiques the sooner approval.